Looking at a spec long in OMDA to diversify my health longs
outside of MCK and CAH.
OVERWEIGHT THESIS
PRICE TARGET: $32.00
We’re Overweight OMDA on a tipping point for cross-selling of
multiple programs, which has positive implications for durability
of growth and an inflection in margins. In addition to GLP-1 care
track serving to extend momentum in its longest standing segment of
Prevention and Weight Health (~75% of revenue), our checks point to
positive customer feedback on Hypertension (~13%) and Diabetes
(~12%). Omada is effectively leveraging technology and AI to scale
the platform, leading to a ~25% increase in total members per
coach. This can be seen in the meaningful 1100 bps expansion in GM
to 63.2% the past 2 years and gives us confidence in the company’s
longer term target of 70%+.
Looking at a spec long
Posted by kalkgrun on 7th of Jan 2026 at 04:11 pm
Looking at a spec long in OMDA to diversify my health longs outside of MCK and CAH.
OVERWEIGHT THESIS
PRICE TARGET: $32.00
We’re Overweight OMDA on a tipping point for cross-selling of multiple programs, which has positive implications for durability of growth and an inflection in margins. In addition to GLP-1 care track serving to extend momentum in its longest standing segment of Prevention and Weight Health (~75% of revenue), our checks point to positive customer feedback on Hypertension (~13%) and Diabetes (~12%). Omada is effectively leveraging technology and AI to scale the platform, leading to a ~25% increase in total members per coach. This can be seen in the meaningful 1100 bps expansion in GM to 63.2% the past 2 years and gives us confidence in the company’s longer term target of 70%+.
OMDA trying to move up
Posted by kalkgrun on 23rd of Jan 2026 at 10:09 am
OMDA trying to move up
hard to count 5 waves
Posted by matt on 23rd of Jan 2026 at 10:10 am
hard to count 5 waves down on that, looks like more 1,2,3,4